The AUSCO study assessed the artificial urinary sphincter's impact on incontinence and quality of life in men post-prostate surgery or with other urinary issues. Conducted across 18 sites, the study ...

ALLO-316 demonstrates significant anti-tumor activity in CD70-positive advanced ccRCC, with a 50% overall response rate in high CD70 expression patients. The therapy maintains a manageable safety ...

PSMA-PET imaging enhances precision in radiation therapy for prostate cancer, improving treatment efficacy by accurately targeting cancerous areas. Emory study showed PET-guided radiation ...

The study involved a large international, multi-center cohort of approximately 4,000 patients undergoing inflatable penile prosthesis surgery. No significant differences in intraoperative or ...

Aquablation with the HYDROS System integrates AI, cystoscopic, and ultrasonic imaging for personalized treatment planning in benign prostatic hyperplasia. Understanding transrectal ultrasonography, ...

mCSPC treatment requires personalized approaches, considering disease burden, patient comorbidities, and genetic profiles to optimize outcomes. There is a significant need for more effective ...

Prostate cancer treatment is linked to a higher risk of long-term complications, persisting up to 12 years post-treatment. The study utilized data from large preventative trials, comparing treated and ...

Standardized guidelines for chaperone use are crucial to ensure consistency and enhance the patient-physician experience in genitourinary exams. Institutions vary in who can serve as a chaperone, with ...

Patient satisfaction is high due to the adaptive delivery of information and encouragement of feedback. Jenson incorporates common patient concerns into lectures, ensuring comprehensive information ...

ONCT-534 trial was terminated due to lack of clinically meaningful improvement and dose-limiting toxicity in high-dose patients. Updated data showed potential in twice-daily dosing, with one patient ...

Canadian provinces exhibit significant disparities in TURP reimbursement rates, with 20%-30% differences and no alignment with the cost-of-living index. Advanced BPH techniques like Greenlight and ...

Padeliporfin VTP demonstrated an 86% complete response rate in patients with low-grade UTUC during the induction treatment phase. The therapy was well-tolerated, with most adverse events being mild ...